Teladoc Health Inc/ US87918A1051 /
2024-11-15 6:01:10 PM | Chg. -0.06 | Volume | Bid6:01:14 PM | Ask6:01:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.90USD | -0.61% | 5.07 mill. Turnover: 41.38 mill. |
8.90Bid Size: 300 | 8.91Ask Size: 1,300 | 1.39 bill.USD | 0.00% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -2.73 USD | -49.07% |
EPS Diluted: | -2.73 USD | -49.07% |
Revenues per Share: | 12.95 USD | 7.16% |
Book Value per Share: | 102.24 USD | -41.74% |
Cash Flow per Share: | 1.24 USD | - |
Dividend per Share: | 0.00 USD | - |
Total | in mill. | |
Revenues: | 2,032.70 USD | 85.80% |
Net Income: | -428.80 USD | -11.61% |
Operating Cash Flow: | 194.00 USD | - |
Cash and Cash Equivalents: | 893.50 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 0.68 | 7.09 |
P/BV ratio: | 0.09 | 0.90 |
P/CF Ratio: | 7.17 | 74.28 |
PEG: | 0.07 | - |
Earnings Yield: | -30.81% | -2.97% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 1.39 bill. USD | 14.41 bill. USD |
Free Float Market Cap.: | 859.32 mill. USD | 8.91 bill. USD |
Market Cap. / Employee: | 272,643.0471 USD | 2.83 mill. USD |
Shares Outstanding: | 160.47 mill. |
Profitability
Gross Profit Margin: | 68.01% |
EBIT Margin: | -13.07% |
Net Profit Margin: | -21.10% |
Return on Equity: | -2.67% |
Return on Assets: | -2.42% |
Financial Strength
Liquidity I / Cash Ratio: | 269.94% |
Liquidity II / Quick Ratio: | 321.00% |
Liquidity III / Current Ratio: | 370.21% |
Debt / Equity Ratio: | 10.52% |
Dynam. Debt / Equity Ratio: | 870.52% |
Efficiency
Employees: | 5,100 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 398,568.63 USD |
Net Income / Employee: | -84,078.43 USD |
Total Assets / Employee: | 3,477,372.55 USD |
* Fiscal Year End: | 2021-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |